Cargando…
Treatment Response in Enteric Fever in an Era of Increasing Antimicrobial Resistance: An Individual Patient Data Analysis of 2092 Participants Enrolled into 4 Randomized, Controlled Trials in Nepal
BACKGROUND. Enteric fever, caused by Salmonella Typhi and Salmonella Paratyphi A, is the leading cause of bacterial febrile disease in South Asia. METHODS. Individual data from 2092 patients with enteric fever randomized into 4 trials in Kathmandu, Nepal, were pooled. All trials compared gatifloxaci...
Autores principales: | Thompson, Corinne N., Karkey, Abhilasha, Dongol, Sabina, Arjyal, Amit, Wolbers, Marcel, Darton, Thomas, Farrar, Jeremy J., Thwaites, Guy E., Dolecek, Christiane, Basnyat, Buddha, Baker, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434338/ https://www.ncbi.nlm.nih.gov/pubmed/28329181 http://dx.doi.org/10.1093/cid/cix185 |
Ejemplares similares
-
Undifferentiated Febrile Illness in Kathmandu, Nepal
por: Thompson, Corinne N., et al.
Publicado: (2015) -
Differential Epidemiology of Salmonella Typhi and Paratyphi A in Kathmandu, Nepal: A Matched Case Control Investigation in a Highly Endemic Enteric Fever Setting
por: Karkey, Abhilasha, et al.
Publicado: (2013) -
Gatifloxacin Versus Ofloxacin for the Treatment of Uncomplicated Enteric Fever in Nepal: An Open-Label, Randomized, Controlled Trial
por: Koirala, Samir, et al.
Publicado: (2013) -
Salmonella Typhi and Salmonella Paratyphi A elaborate distinct systemic metabolite signatures during enteric fever
por: Näsström, Elin, et al.
Publicado: (2014) -
Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an open-label, randomised, controlled trial
por: Arjyal, Amit, et al.
Publicado: (2011)